Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

GlobalData spotlights brain health in women, forecasts Alzheimer’s market to reach $16 billion in 2030

The Women’s Brain Health Initiative (WBHI) is set to host its fifth annual Women’s Brain Health Day on 2 December 2023, advocating for the brain health of women amid a rising Alzheimer’s epidemic. As Alzheimer’s disproportionately affects women, constituting 70% of diagnoses, the event aims to shed light on preventive measures. Emphasizing the vital role […]
Read more

Home-based medical devices will bring fundamental change in elderly healthcare landscape, says GlobalData

The demand for home-based medical devices is driven by an aging population, advancements in technology, and the global shift towards personalized healthcare. From glucose monitors for diabetics to wearable ECG monitors for cardiac patients, the diversity of offerings is expanding rapidly. These devices will fundamentally alter the healthcare landscape of the elderly and play a […]
Read more

Japan sleep apnea equipment market to reach $100 million in 2030, forecasts GlobalData

Owing to increasing occurrences of stress and depression, obesity, long working hours, and high incidences of diabetes, Japan’s market for sleep apnea diagnostic equipment is expected to reach $100 million in 2030, forecasts GlobalData, a leading data and analytics company. GlobalData’s report, “Sleep Apnea Diagnostic Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base […]
Read more

Robotic surgical systems market in China to grow at 12% CAGR through 2033, forecasts GlobalData

China is experiencing a surge in the adoption of robotic systems across various healthcare domains. As the demand for advanced medical technologies continues to escalate, robotic systems are becoming integral to surgical procedures, diagnostic processes, and patient care. Against this backdrop, the robotic surgical systems market in China is expected to grow at a compound […]
Read more

Masimo’s medical watch regulatory approval to bolster remote patient monitoring space, says GlobalData

In the ever-evolving landscape of healthcare technology, medical smartwatches are emerging as transformative devices that seamlessly integrate health monitoring into our daily lives. One notable development in this space is the recent FDA clearance for Masimo‘s medical watch for both prescription and over-the-counter (OTC) use. The clearance will provide a significant boost to the remote […]
Read more

FDA’s recall of stolen laryngoscopes highlights need for increased vigilance on online healthcare marketplace, says GlobalData

In a recent development, the Food and Drug Administration (FDA) issued a medical device recall, targeting stolen Medtronic laryngoscopes that were illicitly sold on the popular online platform, Facebook Marketplace. This unprecedented move highlights the pressing need for increased vigilance in the realm of online commerce, particularly within the healthcare sector, says GlobalData, a leading […]
Read more

Next-generation sequencing breakthroughs drive personalized medicine into mainstream healthcare, says GlobalData

The landscape of next-generation sequencing (NGS) is undergoing a transformative shift, with the cost of sequencing plummeting to less than $100 per genome. This drastic reduction, fueled by intense competition and technological advancements, has propelled the widespread adoption of personalized medicine. This evolution holds the promise of tailoring medical interventions to individual genetic profiles for […]
Read more

Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in cardiovascular disease, says GlobalData

The first human clinical trial of a novel gene-editing technique known as base editing has shown promising results in maintaining healthy levels of cholesterol. In the trial by Verve Therapeutics, physicians injected patients with a Clustered Regularly Interspace Short Palindromic Repeats (CRISPR)-based gene editing therapy called VERVE-101, which inactivated the liver gene PCSK9 that typically […]
Read more

GlobalData emphasizes balancing innovation and accessibility in in vitro diagnostics market

In the dynamic landscape of in vitro diagnostics (IVD), transformative technologies are revolutionizing medical solutions. The market brings forth innovative answers to diverse medical conditions. However, the challenges within the IVD realm require thoughtful consideration. A crucial focus on enhancing accessibility, personalizing treatment decisions, and pioneering advancements in cancer diagnostics emerges as imperative for the […]
Read more

Diagnosed sepsis cases in China to grow at 2% CAGR through 2033, forecasts GlobalData

Sepsis represents a significant public health challenge, marked by elevated morbidity, high mortality rates, and substantial economic strain. As emerging technologies continue to evolve, there is a positive anticipation that diagnostic methods and rates for sepsis will witness significant improvement in China. Against this backdrop, China’s incidence of diagnosed sepsis cases is expected to grow […]
Read more

Xenter new smart guidewire for TAVR procedures could replace traditional guidewires, says GlobalData

US-based Xenter has recently unveiled a new dual-sensor investigational guidewire for use during transcatheter aortic valve replacement (TAVR) procedures. The wireless product poses potential competition to traditional guidewires in the rapidly growing TAVR market, which is set to reach $18.8 billion in 2033, forecasts GlobalData, a leading data and analytics company. The dual sensor guidewire […]
Read more

FDA’s new initiative comes at critical time for medical innovation in AI and ML technologies, says GlobalData

Healthcare is one of the industries where artificial intelligence (AI) is used and applied most frequently. The US Food and Drug Administration (FDA) has recently taken a bigger step towards medical device regulation improvement, creating a new advisory committee to better understand the advantages and disadvantages of adopting technologies like AI and ML in healthcare […]
Read more

Robotic surgical systems market to reach $3.3 billion in 2023 despite Intuitive Surgical stock decline, predicts GlobalData

Following the release of its Q3 earnings, Intuitive Surgical experienced an 8% decline in share price during pre-market trading. Notably, Intuitive Surgical holds the position of the leading player in the robotic surgical systems market, boasting an estimated global market share of 57%. Nevertheless, the global outlook remains robust, with the robotic surgical systems market […]
Read more

WHO’s move for regulation of AI in healthcare highlights risks posed by usage of AI tools, says GlobalData

The World Health Organization (WHO) has outlined several considerations for the regulation of artificial intelligence (AI) in healthcare. The WHO recently released a new publication, in which it listed key regulatory considerations, which touch on the importance of establishing safety and effectiveness in AI tools, making systems available to those who need them, and fostering […]
Read more

Bicycle Health, Override Health partnership to significantly impact healthcare IT industry, says GlobalData

The current era is witnessing remarkable advancements in telehealth, healthcare technology, and innovations in patient care. Early in October, Bicycle Health and Override Health partnered in the fight against opioid use disorder (OUD) and chronic pain. This dynamic partnership could have a large impact on the healthcare IT industry as well as transform patient care, […]
Read more
1 … 17 18 19 20 21 … 51